Rely on Worldwide’s History of Groundbreaking Work for Your Stem Cell Expansion Clinical Trial
Allogeneic stem cell transplantation has proven to be an effective treatment for numerous diseases, including cancers and degenerative diseases. As the demand for hematopoietic stem cells (HSCs) exceeds supply, researchers are driven to seek out mechanisms to generate HSCs from non-hematological origin cells. As knowledge is increasing on regulation of stem cell proliferation, more work is needed to translate these advancements into clinically applicable protocols for stem cell expansion.
Worldwide Clinical Trials has been achieving groundbreaking results in central nervous system disorders for over 30 years, before dementia and related conditions were articulated. In the 21st century, as research moves toward regenerative medicine, we are poised to take on your stem cell expansion work. Our relationships with thought leaders and academic organizations give us access to frontline research advancements, while at the same time keeping us apprised of bioethical considerations that influence regulatory trends and guidance. Combining our long-standing culture of dedicated and accessible project management with state-of-the-art data collection and monitoring technology, we can assure you of flexible service and reliable data delivered on time and at a reasonable cost. From Phase I-IV clinical trials to real-world evidence studies, count on Worldwide Clinical Trials.